We first validated the importance of Cxcr4 in AML by transducing Cas9+dsRed+MLL-AF9 leukemia cells with two different sgRNA-expressing vectors targeting Cxcr4 and coexpressing GFP (Figure 2A). This evidence concerns the gene MLLT3 and acute myeloid leukemia.